Patient Compliance

Small Canadian study measures markers of cell proliferation

Low tumour oxygenation linked with biochemical relapse within 48 months of treatment

Less radioiodine as effective as higher dose, studies show

Oral MEK inhibitor produces ‘striking’ results in early clinical trial

After years of studying thousands of tumour samples, researchers in Canada, Britain and Norway have reclassified the disease into 10 new categories

A private insurance sector and removing constraints on physicians would lead to better healthcare in Ontario, according to Mark Rovere, associate director of health policy studies at The Fraser Institute, a conservative think tank based in Vancouver.

The Parkinson Society Canada, in partnership with leading movement disorder specialists and neurologists from across Canada, has launched the first Canadian Guidelines on Parkinson’s Disease.